CHIMERA PEPTIDES: ENGINEERING NOVEL THERAPEUTICS

Chimera Peptides: Engineering Novel Therapeutics

Hybrid peptide sequences represent the exciting strategy for designing innovative drug candidates. These kinds of molecules involve distinct peptide domains originating from different sources , enabling the production of unique interaction activities. The design strategy can circumvent drawbacks

read more